GGT (GGT) files Rule 144 notice to sell 9,000 common shares
Rhea-AI Filing Summary
GGCP, Inc. has filed a Rule 144 notice to sell 9,000 common shares of the issuer through G.research, LLC on the NYSE, with an approximate aggregate market value of $37,635.00. The filing notes that there are 37,464,640 common shares outstanding and lists the anticipated sale date as 12/09/2025.
The 9,000 shares to be sold were acquired from the issuer on 08/25/2021 via a dividend reinvestment transaction, with payment on the same date. Over the past three months, GGCP, Inc. has sold additional common shares of the same issuer: 9,000 shares on 12/08/2025 for gross proceeds of $37,564.20, 2,000 shares on 12/05/2025 for $8,307.60, and 31,000 shares on 10/27/2025 for $125,137.00.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for GGT disclose?
The notice shows that GGCP, Inc. plans to sell 9,000 common shares of the issuer through G.research, LLC on the NYSE, with an approximate aggregate market value of $37,635.00 and an expected sale date of 12/09/2025.
How many GGT shares has GGCP, Inc. sold recently?
Over the past three months, GGCP, Inc. has sold common shares of the issuer in three transactions: 9,000 shares on 12/08/2025 for $37,564.20, 2,000 shares on 12/05/2025 for $8,307.60, and 31,000 shares on 10/27/2025 for $125,137.00.
How were the 9,000 GGT shares in the planned sale originally acquired?
The 9,000 common shares covered by the planned Rule 144 sale were acquired from the issuer on 08/25/2021 through a dividend reinvestment transaction, with payment also dated 08/25/2021.
What is the total number of GGT common shares outstanding mentioned in the filing?
The notice states that there are 37,464,640 common shares of the issuer outstanding at the time of the planned sale.
Which broker is handling the planned GGT share sale under Rule 144?
The planned sale of 9,000 common shares is to be executed through G.research, LLC, located at One Corporate Center, Rye, NY 10580, on the NYSE.
What does the Form 144 representation say about undisclosed information?
The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.